By approximately Day 45, the participant described: improved overhead movement reduced radiating pain lower baseline pain intensity from 8/10 VAS to 6/10 VAS restored work capacity while still emphasizing incomplete recovery
Patients with pre-existing liver disease should discuss CoQ10 use with their hepatologist, particularly if they have severe hepatic impairment, as altered metabolism could theoretically affect supplement handling
IM vitamin D may be considered for patients with significantly low levels, malabsorption, or difficulty maintaining adequate status with oral supplementation alone
A major clinical trial with 3,500 participants showed that semaglutide reduces disease progression by 24% and lowers the risk of kidney failure and cardiovascular death by 5%
Building on these ideas, Aviv and Shay ( In epidemiological studies, TL was repeatedly found to reflect the risk for aging-related chronic pathological conditions